 |
Cladribine |
|---|---|
| Trade Name | Leustatin Injection |
| Orphan Indication | Hairy cell leukemia |
| USA Market Approval | USA |
| USA Designation Date | 1990-11-15 00:00:00 |
| Sponsor | R. W. Johnson Pharmaceutical Research Institute;Route 202, P.O. Box 300;Raritan, New Jersey, 08869 |
